Politecnico di Milano

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Webinars

Preparing industry leaders for digital transformation

Digital transformation is taking root in every major industry, and healthcare and life sciences are no exception.

News

Politecnico di Milano, Healthware team up to offer executive...

MIP, the Business School of Politecnico di Milano, the largest technical university, is partnering with Healthware Group, a digital health consultancy (and pharmaphorum’s parent company)

News

Chiesi signs $1.9bn deal to buy KalVista and its HAE drug

Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.

Sales & Marketing

Using AI-driven synthetic personas to take your insights fur...

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.

Editor's Picks